DEA schedule
Is rivastigmine a controlled substance?
Federal schedule for rivastigmine from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Rivastigmine is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and rivastigmine is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted rivastigmine?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 72 prescription listings from 20 labelers, none with a DEA schedule |
| DEA controlled substances list | rivastigmine is not on the list |
Rivastigmine NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0078-0503 | Exelon | patch, extended release | 13.3 mg/24h | Novartis Pharmaceuticals Corporation | None |
| 66758-144 | Exelon | patch, extended release | 13.3 mg/24h | Sandoz Inc | None |
| 0078-0501 | Exelon | patch, extended release | 4.6 mg/24h | Novartis Pharmaceuticals Corporation | None |
| 66758-142 | Exelon | patch, extended release | 4.6 mg/24h | Sandoz Inc | None |
| 0078-0502 | Exelon | patch, extended release | 9.5 mg/24h | Novartis Pharmaceuticals Corporation | None |
| 66758-143 | Exelon | patch, extended release | 9.5 mg/24h | Sandoz Inc | None |
| 0378-9072 | Rivastigmine | patch | 13.3 mg/24h | Mylan Pharmaceuticals Inc. | None |
| 65162-749 | Rivastigmine | patch | 13.3 mg/24h | Amneal Pharmaceuticals LLC | None |
| 0378-9070 | Rivastigmine | patch | 4.6 mg/24h | Mylan Pharmaceuticals Inc. | None |
| 65162-825 | Rivastigmine | patch | 4.6 mg/24h | Amneal Pharmaceuticals LLC | None |
| 0378-9071 | Rivastigmine | patch | 9.5 mg/24h | Mylan Pharmaceuticals Inc. | None |
| 65162-826 | Rivastigmine | patch | 9.5 mg/24h | Amneal Pharmaceuticals LLC | None |
| 0781-7313 | Rivastigmine | patch, extended release | 13.3 mg/24h | Sandoz Inc | None |
| 16714-117 | Rivastigmine | patch, extended release | 13.3 mg/24h | Northstar Rx LLC. | None |
| 70710-1198 | Rivastigmine | patch, extended release | 13.3 mg/24h | Zydus Pharmaceuticals USA Inc. | None |
| 70771-1951 | Rivastigmine | patch, extended release | 13.3 mg/24h | Zydus Lifesciences Limited | None |
| 0781-7304 | Rivastigmine | patch, extended release | 4.6 mg/24h | Sandoz Inc | None |
| 70710-1196 | Rivastigmine | patch, extended release | 4.6 mg/24h | Zydus Pharmaceuticals USA Inc. | None |
| 70771-1949 | Rivastigmine | patch, extended release | 4.6 mg/24h | Zydus Lifesciences Limited | None |
| 0781-7309 | Rivastigmine | patch, extended release | 9.5 mg/24h | Sandoz Inc | None |
| 16714-116 | Rivastigmine | patch, extended release | 9.5 mg/24h | Northstar Rx LLC. | None |
| 70710-1197 | Rivastigmine | patch, extended release | 9.5 mg/24h | Zydus Pharmaceuticals USA Inc. | None |
| 70771-1950 | Rivastigmine | patch, extended release | 9.5 mg/24h | Zydus Lifesciences Limited | None |
| 0904-7107 | Rivastigmine Tartrate | capsule | 1.5 mg/1 | Major Pharmaceuticals | None |
| 33342-089 | RIVASTIGMINE TARTRATE | capsule | 1.5 mg/1 | Macleods Pharmaceuticals Limited | None |
| 46708-063 | Rivastigmine Tartrate | capsule | 1.5 mg/1 | Alembic Pharmaceuticals Limited | None |
| 55111-352 | Rivastigmine Tartrate | capsule | 1.5 mg/1 | Dr. Reddy's Laboratories Limited | None |
| 60687-777 | Rivastigmine Tartrate | capsule | 1.5 mg/1 | American Health Packaging | None |
| 62135-900 | Rivastigmine Tartrate | capsule | 1.5 mg/1 | Chartwell RX, LLC | None |
| 62332-063 | Rivastigmine Tartrate | capsule | 1.5 mg/1 | Alembic Pharmaceuticals Inc. | None |
| 62756-145 | Rivastigmine Tartrate | capsule | 1.5 mg/1 | Sun Pharmaceutical Industries, Inc. | None |
| 65862-648 | Rivastigmine Tartrate | capsule | 1.5 mg/1 | Aurobindo Pharma Limited | None |
| 71209-012 | Rivastigmine Tartrate | capsule | 1.5 mg/1 | Cadila Pharmaceuticals Limited | None |
| 72241-011 | Rivastigmine Tartrate | capsule | 1.5 mg/1 | Modavar Pharmaceuticals LLC | None |
| 33342-090 | RIVASTIGMINE TARTRATE | capsule | 3 mg/1 | Macleods Pharmaceuticals Limited | None |
| 46708-064 | Rivastigmine Tartrate | capsule | 3 mg/1 | Alembic Pharmaceuticals Limited | None |
| 55111-353 | Rivastigmine Tartrate | capsule | 3 mg/1 | Dr. Reddy's Laboratories Limited | None |
| 62135-901 | Rivastigmine Tartrate | capsule | 3 mg/1 | Chartwell RX, LLC | None |
| 62332-064 | Rivastigmine Tartrate | capsule | 3 mg/1 | Alembic Pharmaceuticals Inc. | None |
| 62756-146 | Rivastigmine Tartrate | capsule | 3 mg/1 | Sun Pharmaceutical Industries, Inc. | None |
Showing 40 of 72 listings.
Questions
Is rivastigmine a controlled substance?
No. Rivastigmine is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and rivastigmine is not on the DEA controlled substances list.
Is rivastigmine a narcotic?
No. Rivastigmine is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Cholinesterase Inhibitor.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Rivastigmine
- What is Rivastigmine used for?FDA label uses
- Generic for ExelonFDA Orange Book
- What is Exelon used for?FDA label uses
- Is Exelon a controlled substance?Federal schedule
- Cholinesterase Inhibitors listFDA drug class
- NDC 0078-0501Rivastigmine NDC record
- NDC 0078-0502Rivastigmine NDC record
- NDC 0078-0503Rivastigmine NDC record